Philippe Schaison

Philippe Schaison has extensive experience in the biopharmaceutical and medical aesthetics industries, holding pivotal leadership roles across various organizations. Currently, Schaison serves on the Board of Directors for SENTÉ, The Galien Foundation, AIVITA Biomedical, Inc., Raziel Therapeutics, Forefront Dermatology, Sientra, Inc., and Revelle Aesthetics, Inc. Past roles include President at Allergan and Clarins and CEO positions at Syneron Candela and Aesthetic Factors. Schaison's achievements include taking Syneron Candela private and driving significant increases in company value. Schaison holds an MBA in Marketing from HEC Paris and a PharmD from Université Paris Cité.